These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34707037)

  • 1. t(9;14)(p13;q32)/PAX5-IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma.
    Ohno H; Takeoka K; Kishimori C; Nakagawa M; Fukutsuka K; Maekawa F; Hayashida M; Akasaka T; Sumiyoshi S
    J Clin Exp Hematop; 2021 Dec; 61(4):216-220. PubMed ID: 34707037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse large B-cell lymphoma carrying t(9;14)(p13;q32)/PAX5-immunoglobulin heavy chain gene is characterized by nuclear positivity of MUM1 and PAX5 by immunohistochemistry.
    Ohno H; Nakagawa M; Kishimori C; Fukutsuka K; Maekawa F; Takeoka K; Hayashida M; Sakamoto S; Akasaka T; Honjo G
    Hematol Oncol; 2020 Apr; 38(2):171-180. PubMed ID: 31955451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of primary diffuse large B-cell lymphoma of the CNS associated with t(8;14)(q24;q32) or t(3;14)(q27;q32) identified by G-banding and fluorescence in situ hybridization applied to metaphase spreads.
    Ohno H; Maekawa F; Nakagawa M; Chagi Y; Nakagawa M; Kishimori C; Fukutsuka K; Hayashida M; Takeoka K; Maruyama W; Ukyo N; Sumiyoshi S
    J Clin Exp Hematop; 2022 Dec; 62(4):242-248. PubMed ID: 36436932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diverse B-cell tumors associated with t(14;19)(q32;q13)/IGH::BCL3 identified by G-banding and fluorescence in situ hybridization.
    Ohno H; Maekawa F; Hayashida M; Nakagawa M; Fukutsuka K; Matsumura M; Takeoka K; Maruyama W; Ukyo N; Sumiyoshi S; Tanaka Y; Haga H
    J Clin Exp Hematop; 2024; 64(1):21-31. PubMed ID: 38538317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
    Hamada T; Yonetani N; Ueda C; Maesako Y; Akasaka H; Akasaka T; Ohno H; Kawakami K; Amakawa R; Okuma M
    Br J Haematol; 1998 Aug; 102(3):691-700. PubMed ID: 9722295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel five-way translocation, t(3;9;13;8;14)(q27;p13;q32;q24;q32), with concurrent MYC and BCL6 rearrangements in a primary bone marrow B-cell lymphoma.
    Yamamoto K; Matsuoka H; Yakushijin K; Funakoshi Y; Okamura A; Hayashi Y; Minami H
    Cancer Genet; 2011 Sep; 204(9):501-6. PubMed ID: 22018272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
    Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
    Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.
    Iida S; Rao PH; Nallasivam P; Hibshoosh H; Butler M; Louie DC; Dyomin V; Ohno H; Chaganti RS; Dalla-Favera R
    Blood; 1996 Dec; 88(11):4110-7. PubMed ID: 8943844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biallelic BCL6 rearrangements by dual t(3;14)(q27;q32) and t(3;22)(q27;q11) translocations in diffuse large B-cell lymphoma.
    Nakamura Y; Itoh Y; Kakegawa E; Uchida Y; Ichimura T; Sasaki A
    J Clin Exp Hematop; 2022; 62(4):268-272. PubMed ID: 36575004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interphase detection of BCL6/IgH fusion gene in non-Hodgkin lymphoma by fluorescence in situ hybridization.
    Ueda Y; Nishida K; Miki T; Horiike S; Kaneko H; Yokota S; Misawa S; Abe T; Kashima K; Taniwaki M
    Cancer Genet Cytogenet; 1997 Dec; 99(2):102-7. PubMed ID: 9398863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
    Ohno H; Ueda C; Akasaka T
    Leuk Lymphoma; 2000 Feb; 36(5-6):435-45. PubMed ID: 10784387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.
    Busslinger M; Klix N; Pfeffer P; Graninger PG; Kozmik Z
    Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6129-34. PubMed ID: 8650231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of t(14;18)-negative follicular lymphoma to plasmablastic lymphoma: a case report with analysis of genetic evolution.
    Lim S; Koh J; Bae JM; Yun H; Lee C; Paik JH; Kim TM; Jeon YK
    Diagn Pathol; 2024 Jun; 19(1):86. PubMed ID: 38909266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
    Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
    Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma.
    Morrison AM; Jäger U; Chott A; Schebesta M; Haas OA; Busslinger M
    Blood; 1998 Nov; 92(10):3865-78. PubMed ID: 9808580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel double-hit, t(8;22)(q24;q11)/MYC-IGL and t(14;15)(q32;q24)/IGH-BCL2A1, in diffuse large B-cell lymphoma.
    Akasaka T; Kishimori C; Fukutsuka K; Nakagawa M; Takeoka K; Hayashida M; Honjo G; Ohno H
    Cancer Genet; 2017 Aug; 214-215():26-31. PubMed ID: 28595732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-positive diffuse large B-cell lymphoma carrying a t(9;14)(p13;q32) translocation.
    Ohno H; Nishikori M; Haga H; Isoda K
    Int J Hematol; 2009 Jun; 89(5):704-8. PubMed ID: 19430986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
    Souabni A; Jochum W; Busslinger M
    Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
    Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
    Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro Epstein-Barr virus-immortalized lymphoma cell line carrying t(9;14)(p13;q32) chromosome abnormality, derived from splenic lymphoma with villous lymphocytes.
    Daibata M; Taguchi T; Nemoto Y; Iwasaki S; Ohtsuki Y; Taguchi H
    Int J Cancer; 2006 Jan; 118(2):513-7. PubMed ID: 16049984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.